(Q46952830)

26 December 2017

title

Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial (English)

1 reference

26 December 2017

attention deficit hyperactivity disorder

1 reference

1 reference

1 reference

5

Luis Augusto Rohde

1 reference

26 December 2017

author name string

Silza Tramontina

1

1 reference

26 December 2017

Cristian Patrick Zeni

2

1 reference

26 December 2017

Gabriel Ferreira Pheula

3

1 reference

26 December 2017

Carla Ketzer de Souza

4

1 reference

26 December 2017

publication date

1 October 2007

1 reference

26 December 2017

published in

C N S Spectrums

1 reference

26 December 2017

volume

12

1 reference

26 December 2017

issue

10

1 reference

26 December 2017

page(s)

758-762

1 reference

26 December 2017

Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Juvenile bipolar disorder in Brazil: clinical and treatment findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Risk of Substance Use Disorders in Adolescents With Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

ADHD in Brazil: the DSM-IV criteria in a culturally different population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

Aripiprazole in children and adolescents: clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

7 January 2021

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

7 January 2021

Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

7 January 2021

Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900015443

7 January 2021

10.1017/S1092852900015443

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017